HEADER ANTIMICROBIAL PROTEIN 24-JUL-23 8PXY TITLE CRYSTAL STRUCTURE OF THE TRANSPEPTIDASE LDTMT2 C354S MUTANT FROM TITLE 2 MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH NATURAL SUBSTRATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: L,D-TRANSPEPTIDASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LDT 2,LDT(MT2); COMPND 5 EC: 2.3.2.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PEPTIDOGLYCAN TETRAPEPTIDE; COMPND 9 CHAIN: B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: LDTB, MT2594, V735_02606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 9 ORGANISM_TAXID: 1773 KEYWDS LDTMT2, SUBSTRATE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, L, D- KEYWDS 2 TRANSPEPTIDASE, ANTIMICROBIAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.DE MUNNIK,C.J.SCHOFIELD REVDAT 1 07-AUG-24 8PXY 0 JRNL AUTH M.DE MUNNIK,C.J.SCHOFIELD JRNL TITL CRYSTAL STRUCTURE OF THE TRANSPEPTIDASE LDTMT2 C354S MUTANT JRNL TITL 2 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH NATURAL JRNL TITL 3 SUBSTRATE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.18.2_3874: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 23830 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 1161 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 59.5400 - 4.3000 1.00 3006 163 0.1662 0.1902 REMARK 3 2 4.3000 - 3.4100 1.00 2896 136 0.1663 0.2375 REMARK 3 3 3.4100 - 2.9800 1.00 2841 148 0.2039 0.2470 REMARK 3 4 2.9800 - 2.7100 1.00 2804 147 0.2315 0.2842 REMARK 3 5 2.7100 - 2.5100 1.00 2835 146 0.2528 0.3166 REMARK 3 6 2.5100 - 2.3700 0.99 2764 143 0.2604 0.2738 REMARK 3 7 2.3700 - 2.2500 1.00 2786 130 0.2707 0.3535 REMARK 3 8 2.2500 - 2.1500 0.98 2737 148 0.2713 0.2912 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.14 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2807 REMARK 3 ANGLE : 0.574 3857 REMARK 3 CHIRALITY : 0.048 436 REMARK 3 PLANARITY : 0.003 506 REMARK 3 DIHEDRAL : 11.257 960 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 58 THROUGH 122 ) REMARK 3 ORIGIN FOR THE GROUP (A): 53.8177 7.0887 12.1721 REMARK 3 T TENSOR REMARK 3 T11: 0.2689 T22: 0.2882 REMARK 3 T33: 0.3068 T12: 0.0163 REMARK 3 T13: 0.0445 T23: -0.0070 REMARK 3 L TENSOR REMARK 3 L11: 1.6711 L22: 6.3179 REMARK 3 L33: 3.4060 L12: -0.2426 REMARK 3 L13: 2.2350 L23: 0.5206 REMARK 3 S TENSOR REMARK 3 S11: 0.0779 S12: -0.0210 S13: 0.0332 REMARK 3 S21: -0.1614 S22: -0.0267 S23: -0.0416 REMARK 3 S31: 0.3085 S32: -0.1702 S33: -0.0542 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 123 THROUGH 248 ) REMARK 3 ORIGIN FOR THE GROUP (A): 33.3916 17.5795 10.9384 REMARK 3 T TENSOR REMARK 3 T11: 0.3131 T22: 0.2927 REMARK 3 T33: 0.2369 T12: 0.0100 REMARK 3 T13: 0.0523 T23: 0.0108 REMARK 3 L TENSOR REMARK 3 L11: 2.7525 L22: 0.8555 REMARK 3 L33: 0.4832 L12: -0.1688 REMARK 3 L13: 0.5365 L23: -0.0533 REMARK 3 S TENSOR REMARK 3 S11: 0.0136 S12: -0.1240 S13: -0.0103 REMARK 3 S21: -0.1092 S22: -0.0123 S23: -0.0746 REMARK 3 S31: 0.0171 S32: 0.0617 S33: 0.0052 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 249 THROUGH 407 ) REMARK 3 ORIGIN FOR THE GROUP (A): 2.5993 26.7025 13.7201 REMARK 3 T TENSOR REMARK 3 T11: 0.3300 T22: 0.2855 REMARK 3 T33: 0.2951 T12: 0.0343 REMARK 3 T13: -0.0751 T23: -0.0001 REMARK 3 L TENSOR REMARK 3 L11: 1.4502 L22: 0.7622 REMARK 3 L33: 1.6523 L12: -0.0705 REMARK 3 L13: -0.2983 L23: 0.1459 REMARK 3 S TENSOR REMARK 3 S11: 0.0724 S12: -0.0558 S13: 0.0355 REMARK 3 S21: -0.1579 S22: -0.0824 S23: 0.1332 REMARK 3 S31: -0.2043 S32: -0.2333 S33: 0.0134 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8PXY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292132157. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAY-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : DIALS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23935 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 59.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : 0.13800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : 0.98700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.0, 25% JEFFAMINE ED REMARK 280 -2001 PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 38.30400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.31150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.30400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.31150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 933 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 54 REMARK 465 SER A 55 REMARK 465 ASP A 56 REMARK 465 LEU A 57 REMARK 465 ALA A 408 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 58 CD1 CD2 REMARK 470 VAL A 59 CG1 CG2 REMARK 470 LYS A 61 CD CE NZ REMARK 470 ARG A 104 CD NE CZ NH1 NH2 REMARK 470 GLN A 117 CD OE1 NE2 REMARK 470 LEU A 133 CG CD1 CD2 REMARK 470 LYS A 217 CD CE NZ REMARK 470 LYS A 407 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ALA B 3 C ZGL B 4 N 0.152 REMARK 500 ZGL B 4 C JGO B 5 N 0.141 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 204 -166.37 -160.41 REMARK 500 HIS A 347 -53.11 -143.35 REMARK 500 ASN A 405 40.97 -146.71 REMARK 500 ZGL B 4 -31.37 -138.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ZGL B 4 11.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 931 DISTANCE = 6.14 ANGSTROMS REMARK 525 HOH A 932 DISTANCE = 6.27 ANGSTROMS REMARK 525 HOH A 933 DISTANCE = 6.76 ANGSTROMS DBREF 8PXY A 56 408 UNP O53223 LDT2_MYCTO 56 408 DBREF 8PXY B 3 6 PDB 8PXY 8PXY 3 6 SEQADV 8PXY GLN A 54 UNP O53223 EXPRESSION TAG SEQADV 8PXY SER A 55 UNP O53223 EXPRESSION TAG SEQADV 8PXY SER A 354 UNP O53223 CYS 354 ENGINEERED MUTATION SEQRES 1 A 355 GLN SER ASP LEU LEU VAL PRO LYS LEU THR ALA SER VAL SEQRES 2 A 355 THR ASP GLY ALA VAL GLY VAL THR VAL ASP ALA PRO VAL SEQRES 3 A 355 SER VAL THR ALA ALA ASP GLY VAL LEU ALA ALA VAL THR SEQRES 4 A 355 MET VAL ASN ASP ASN GLY ARG PRO VAL ALA GLY ARG LEU SEQRES 5 A 355 SER PRO ASP GLY LEU ARG TRP SER THR THR GLU GLN LEU SEQRES 6 A 355 GLY TYR ASN ARG ARG TYR THR LEU ASN ALA THR ALA LEU SEQRES 7 A 355 GLY LEU GLY GLY ALA ALA THR ARG GLN LEU THR PHE GLN SEQRES 8 A 355 THR SER SER PRO ALA HIS LEU THR MET PRO TYR VAL MET SEQRES 9 A 355 PRO GLY ASP GLY GLU VAL VAL GLY VAL GLY GLU PRO VAL SEQRES 10 A 355 ALA ILE ARG PHE ASP GLU ASN ILE ALA ASP ARG GLY ALA SEQRES 11 A 355 ALA GLU LYS ALA ILE LYS ILE THR THR ASN PRO PRO VAL SEQRES 12 A 355 GLU GLY ALA PHE TYR TRP LEU ASN ASN ARG GLU VAL ARG SEQRES 13 A 355 TRP ARG PRO GLU HIS PHE TRP LYS PRO GLY THR ALA VAL SEQRES 14 A 355 ASP VAL ALA VAL ASN THR TYR GLY VAL ASP LEU GLY GLU SEQRES 15 A 355 GLY MET PHE GLY GLU ASP ASN VAL GLN THR HIS PHE THR SEQRES 16 A 355 ILE GLY ASP GLU VAL ILE ALA THR ALA ASP ASP ASN THR SEQRES 17 A 355 LYS ILE LEU THR VAL ARG VAL ASN GLY GLU VAL VAL LYS SEQRES 18 A 355 SER MET PRO THR SER MET GLY LYS ASP SER THR PRO THR SEQRES 19 A 355 ALA ASN GLY ILE TYR ILE VAL GLY SER ARG TYR LYS HIS SEQRES 20 A 355 ILE ILE MET ASP SER SER THR TYR GLY VAL PRO VAL ASN SEQRES 21 A 355 SER PRO ASN GLY TYR ARG THR ASP VAL ASP TRP ALA THR SEQRES 22 A 355 GLN ILE SER TYR SER GLY VAL PHE VAL HIS SER ALA PRO SEQRES 23 A 355 TRP SER VAL GLY ALA GLN GLY HIS THR ASN THR SER HIS SEQRES 24 A 355 GLY SER LEU ASN VAL SER PRO SER ASN ALA GLN TRP PHE SEQRES 25 A 355 TYR ASP HIS VAL LYS ARG GLY ASP ILE VAL GLU VAL VAL SEQRES 26 A 355 ASN THR VAL GLY GLY THR LEU PRO GLY ILE ASP GLY LEU SEQRES 27 A 355 GLY ASP TRP ASN ILE PRO TRP ASP GLN TRP ARG ALA GLY SEQRES 28 A 355 ASN ALA LYS ALA SEQRES 1 B 4 ALA ZGL JGO DAL HET ZGL B 4 9 HET JGO B 5 12 HET DAL B 6 6 HET MUB C 1 19 HET NAG C 2 14 HET EPE A 501 15 HET CL A 502 1 HETNAM ZGL D-ALPHA-GLUTAMINE HETNAM JGO MESO-2,6-DIAMINOPIMELIC ACID NH2 HETNAM DAL D-ALANINE HETNAM MUB N-ACETYL-ALPHA-MURAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM CL CHLORIDE ION HETSYN ZGL ISO-D-GLUTAMINE HETSYN JGO (2S,6R)-2,6,7-TRIS(AZANYL)-7-OXIDANYLIDENE-HEPTANOIC HETSYN 2 JGO ACID; (2S,6R)-2,6,7-TRIAMINO-7-OXOHEPTANOIC ACID HETSYN MUB N-ACETYL-MURAMIC ACID; N-ACETYLMURAMIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN EPE HEPES FORMUL 2 ZGL C5 H10 N2 O3 FORMUL 2 JGO C7 H15 N3 O3 FORMUL 2 DAL C3 H7 N O2 FORMUL 3 MUB C11 H19 N O8 FORMUL 3 NAG C8 H15 N O6 FORMUL 4 EPE C8 H18 N2 O4 S FORMUL 5 CL CL 1- FORMUL 6 HOH *337(H2 O) HELIX 1 AA1 ASP A 180 ALA A 187 1 8 HELIX 2 AA2 SER A 306 GLY A 309 5 4 HELIX 3 AA3 PRO A 339 VAL A 342 5 4 HELIX 4 AA4 SER A 358 VAL A 369 1 12 HELIX 5 AA5 GLY A 392 ILE A 396 5 5 HELIX 6 AA6 PRO A 397 GLY A 404 1 8 SHEET 1 AA1 4 LYS A 61 ALA A 64 0 SHEET 2 AA1 4 SER A 80 ALA A 84 -1 O THR A 82 N THR A 63 SHEET 3 AA1 4 ARG A 111 THR A 114 -1 O TRP A 112 N VAL A 81 SHEET 4 AA1 4 GLY A 103 LEU A 105 -1 N ARG A 104 O SER A 113 SHEET 1 AA2 3 VAL A 87 ASN A 95 0 SHEET 2 AA2 3 ARG A 123 GLY A 132 -1 O ASN A 127 N THR A 92 SHEET 3 AA2 3 GLY A 135 GLN A 144 -1 O LEU A 141 N LEU A 126 SHEET 1 AA3 2 HIS A 150 THR A 152 0 SHEET 2 AA3 2 MET A 237 GLY A 239 1 O PHE A 238 N HIS A 150 SHEET 1 AA4 4 PRO A 154 MET A 157 0 SHEET 2 AA4 4 VAL A 170 PHE A 174 -1 O ARG A 173 N TYR A 155 SHEET 3 AA4 4 GLU A 207 ARG A 211 -1 O TRP A 210 N VAL A 170 SHEET 4 AA4 4 ALA A 199 TRP A 202 -1 N TYR A 201 O ARG A 209 SHEET 1 AA5 4 VAL A 163 VAL A 164 0 SHEET 2 AA5 4 VAL A 243 ILE A 249 1 O THR A 248 N VAL A 164 SHEET 3 AA5 4 ALA A 221 VAL A 226 -1 N VAL A 226 O VAL A 243 SHEET 4 AA5 4 ILE A 188 ASN A 193 -1 N ASN A 193 O ALA A 221 SHEET 1 AA6 5 GLU A 271 PRO A 277 0 SHEET 2 AA6 5 ILE A 263 VAL A 268 -1 N LEU A 264 O MET A 276 SHEET 3 AA6 5 VAL A 253 ASP A 258 -1 N THR A 256 O THR A 265 SHEET 4 AA6 5 ILE A 374 VAL A 378 1 O GLU A 376 N ALA A 257 SHEET 5 AA6 5 GLY A 290 ILE A 293 -1 N TYR A 292 O VAL A 375 SHEET 1 AA7 4 ARG A 297 ASP A 304 0 SHEET 2 AA7 4 ARG A 319 GLN A 327 -1 O THR A 320 N MET A 303 SHEET 3 AA7 4 PHE A 334 SER A 337 -1 O VAL A 335 N THR A 326 SHEET 4 AA7 4 LEU A 355 VAL A 357 1 O LEU A 355 N PHE A 334 LINK C ALA B 3 N ZGL B 4 1555 1555 1.49 LINK N ALA B 3 C10 MUB C 1 1555 1555 1.49 LINK C ZGL B 4 N JGO B 5 1555 1555 1.48 LINK C JGO B 5 N DAL B 6 1555 1555 1.47 LINK O4 MUB C 1 C1 NAG C 2 1555 1555 1.40 CISPEP 1 MET A 157 PRO A 158 0 1.39 CISPEP 2 ASN A 193 PRO A 194 0 -2.75 CRYST1 76.608 94.623 58.794 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013053 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010568 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017009 0.00000